Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31611836 | 0.88 | IDO1 (0.31) | IDO1SOD1 | |
| SCHEMBL4245134 | 0.88 | IDO1 (0.31) | IDO1SOD1 | |
| SCHEMBL473195 | 0.80 | IDO1 (0.40) | IDO1SOD1 | |
| SCHEMBL6675245 | 0.80 | IDO1 (0.31) | IDO1SOD1 | |
| SCHEMBL27554604 | 0.79 | SOD1 (0.34) | IDO1SOD1 | |
| SCHEMBL29738705 | 0.78 | IDO1 (0.31) | IDO1SOD1 | |
| SCHEMBL27531973 | 0.78 | IDO1 (0.35) | IDO1 | |
| Boric Acid SCHEMBL27540523 | 0.77 | IDO1 (0.33) | IDO1 | |
| SCHEMBL27554599 | 0.77 | MGLL (0.42) | IDO1 | |
| SCHEMBL985549 | 0.77 | IDO1 (0.34) | IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7902109-B2 | Organometallic compound, catalyst for polymerization of polar group-containing norbornene and process for producing norbornene polymer | FUJIFILM CORPORATION (JP) | 2011-03-08 | — | — | US | disclosed |
| US-20090247729-A1 | ORGANOMETALLIC COMPOUND, CATALYST FOR POLYMERIZATION OF POLAR GROUP-CONTAINING NORBORNENE AND PROCESS FOR PRODUCING NORBORNENE POLYMER | FUJIFILM CORPORATION (JP) | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247729-A1 | ORGANOMETALLIC COMPOUND, CATALYST FOR POLYMERIZATION OF POLAR GROUP-CONTAINING NORBORNENE AND PROCESS FOR PRODUCING NORBORNENE POLYMER | DDT, PHOSPHO1, POF1B | IDO1 3737/4885SOD1 2140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.